Cypralis' Grant

Cypralis raised a round of funding on January 24, 2017. Investors include Innovate UK.

Cypralis is a life sciences company engaged in the preclincial development of nonimmunosuppressive peptidyl-prolyl isomerase (PPIase) inhibitors for a range of potential therapeutic indications, inclu…

Articles about Cypralis' Grant: